Sign in
4/A

Changes in Ownership

Oncotelic Therapeutics, Inc. Filed Acc 0001181431-04-027130

President and CEO bought 2,000 shares at $7.31 ($14,620)

From the SEC's structured data for this filing

Trades in this filing

DRISCOLL FREDERICK W · President and CEO

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2004-05-20 Purchase : show line 1 in the form +2,000 $7.31 $14,620 40,000 D
Open-market purchases · 2,000 sh · avg $7.31 · $14,620
Loading xslF345X02/rrd43296.xml…